StockWatch
·

RADICO KHAITAN LTD.

BSE: 532497

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
5.9K
+13.2%+10.4%
Expenditure
5.6K
+12.4%+8.5%
Net Profit
226.01
+29.0%+69.5%
OPM %
5.95%
+0.46pp+1.71pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.001.6K3.3K4.9K6.6KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

16 results out of 4,000: the rarest earnings of this season, and what happened next

Q1 FY27 · results season · earnings

ResearchDeep dive15 Aug 20266 minIndustrials & Infra

The 76% profit surge that's 80% margin, not volume

premiumization · margin expansion · P&A growth

Result verdictFollow-upQ1 FY2705 Aug 20266 minFMCG

Premiumization in overdrive: 36% P&A growth, margin expansion ahead of guidance

premiumization · P&A growth · margin expansion

TranscriptDeep diveQ1 FY2705 Aug 20266 minFMCG
Latest
Board Meeting28 Jul, 2:07 pm

Radico Khaitan Q1: consolidated PAT jumps 76% YoY to ₹230 Cr on sharp margin expansion

Radico Khaitan opened FY27 with a profit-led beat. Consolidated net profit rose ~76% YoY to ₹229.6 Cr (₹230 Cr) on gross revenue of ₹5,867.7 Cr, up 10.4% YoY; on a net-of-excise basis sales were ~₹1,684 Cr, up ~12% YoY. The disproportionate jump in profit versus the modest topline is the whole story — this was margin, not volume-scale, driven. Adjusted for the ₹6.99 Cr exceptional loss in the year-ago base, PAT growth is ~+67%, still firmly strong. Standalone PAT was ₹226.0 Cr (+69% YoY, EPS ₹16.88); the ₹7.2 Cr joint-venture profit share (vs ₹0.8 Cr a year ago) lifts the consolidated figure a touch higher, so the two bases tell the same premiumisation story. The margin bridge is the key: estimated EBITDA rose to ~₹349 Cr from ~₹232 Cr, taking the EBITDA margin on net sales to roughly 20.7% from ~15.4% a year ago — a >500 bps expansion that already dwarfs management's full-year guidance of ~125 bps. Net profit margin on gross revenue expanded to 3.9% from 2.5% YoY (3.5% last quarter). The lift is consistent with the company's premium-led mix shift; Magic Moments Vodka alone clocked 3.25 million cases in the quarter, and the Prestige-&-Above/luxury push is where the operating leverage is showing up. Finance costs eased to ₹11.7 Cr from ₹15.9 Cr YoY, aiding the print and consistent with the stated goal of turning debt-free in H1 FY27. Against the Street, this is a beat on profitability: Equirus had modelled PAT of ~₹209 Cr and an EBITDA margin of ~19.1%; actual PAT of ₹230 Cr and a ~20.7% margin came in ahead, even as net sales (~₹1,684 Cr) landed a shade below the ₹1,731 Cr estimate. So the quarter confirms — and runs ahead of — the bullish, confident tone management struck on the Q4 concall, when it guided 20% Prestige-&-Above volume growth and 125 bps of FY27 margin expansion. The board approved the unaudited results today (July 28); the 42nd AGM is set for August 7 with the FY26 dividend on the docket. The QoQ optics (PAT +28%, revenue +13%) partly reflect the seasonally softer March quarter and are supporting detail, not the headline — the YoY margin story is what matters.

28 Jul 2026, 02:07 pm

Corporate Events

Board MeetingRADICO
2026
7Aug

Board Meeting

The 42nd Annual General Meeting will be held to receive, con…

BSE Filing
DividendRADICO
2026
31Jul

₹9 / share

BSE Filing
Board MeetingRADICO
2026
28Jul

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing
DividendRADICO
2026
24Jul

₹9 / share

BSE Filing
Board MeetingRADICO
2026
6May

Board Meeting

The Board of Directors at their meeting held on May 6, 2026,…

BSE Filing
DividendRADICO
2025
24Jul

₹4 / share

BSE Filing
Board MeetingRADICO
2024
24Oct

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingRADICO
2024
7Aug

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
DividendRADICO
2024
25Jul

₹3 / share

BSE Filing
Board MeetingRADICO
2024
14May

Board Meeting

Consider and approve Audited Standalone and Consolidated Fin…

BSE Filing
Board MeetingRADICO
2024
6Feb

Board Meeting

consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingRADICO
2023
6Nov

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing